Attendees at Piedmont Heart’s 2019 Napa Valley Cardiology Conference agreed that treating tricuspid regurgitation (TR) can be tricky. Vinnie Bapat, M.D., who leads the mitral and tricuspid therapies program at New York-Presbyterian/Columbia University Medical Center, outlined some of the challenges, highlighted new tricuspid therapies and shared a case study.